Given as a combined vaccine with polio, tetanus and diphtheria.

Those travelling to an area with poor access to medical attention who have not had a booster in the last 10 years. Additional vaccine information: If your childhood schedule was incomplete, seek guidance about additional doses. In the UK, tetanus vaccine is combined with polio and diphtheria.

A single injection.

2 weeks before travel

General issues: Patients who have had a serious reaction (”anaphylaxis”) to a previous dose of this vaccine or its constituents. Specific issues: Unstable epilepsy.

There is no evidence of risk.

10 years

Very few. Temporary tenderness at the site of the injection

£50 per dose

Travellers will receive an active vaccine. This is a purified, inactivated preparation of hepatitis A virus.

Those travelling to or who will be residing in areas where the disease is common, particularly if sanitation and food hygiene is likely to be poor. Additional vaccine information: The vaccine is also available combined with hepatitis B or typhoid.

A single injection 2 weeks prior to travel. Then a reinforcing dose 6-12 months later.

2 weeks before travel

General issues: Patients who have had a serious reaction (”anaphylaxis”) to a previous dose of this vaccine or its constituents. Specific issues: One brand of vaccine ”Epaxal” should not be given to those who have had anaphylaxis to hens’ eggs.

There is no evidence of risk.

25 years

Very few. Temporary tenderness at the site of the injection.

Very few. Temporary tenderness at the site of the injection.

£82 per dose

Travellers to areas of high or intermediate prevalence who place themselves at risk when abroad should be offered immunisation. The behaviours that place them at risk will include sexual activity, injecting drug use, undertaking relief aid work and/or participating in contact sports. Travellers are also at risk of acquiring infection as a result of medical or dental procedures carried out in countries where unsafe therapeutic injections are a possibility.

Additional vaccine information: The vaccine is available combined with hepatitis A vaccine.

Those travelling to an area with poor access to medical attention who have not had a booster in the last 10 years. Additional vaccine information: If your childhood schedule was incomplete, seek guidance about additional doses. In the UK, tetanus vaccine is combined with polio and diphtheria.

There are several different schedules of vaccination. Usually we advise three doses at 0, 1 and 6 months.

2 months before travel

General issues: Patients who have had a serious reaction (”anaphylaxis”) to a previous dose of this vaccine or its constituents. Specific issues: Vaccination should not replace other protective measures against infection, for example the use of condoms.

There is no evidence of risk.

Life cover after a full 3 dose course

Very few. Temporary tenderness at the site of the injection

£62 per dose

Inactivated tick borne encephalitis virus.

Travellers particularly for spring and summer travel in warm, forested parts of the at risk areas. Individuals who hike, camp, hunt and undertake fieldwork in endemic forested areas should be vaccinated.

3 doses at 0, 1 and 6 months.

3 months before travel

General issues: A confirmed anaphylactic reaction to a previous dose of TBE vaccine, one of the vaccine components or a confirmed anaphylactic reaction to egg ingestion.

There is no evidence of risk.

3 years

Reported reactions to TBE vaccine are rare. Local reactions such as swelling, pain and redness at the injection site may occur.

£70 per dose

BCG is a Live safe attenuated (weakened form) of Tuberculosis (TB)

BCG vaccination can be given safely to any person of any age, from new born through to old age. This is a once only vaccination in the UK and is highly recommended by the DH to specific groups at higher risk of exposure to TB.

BCG is a single once only injection given by specially trained nurses where there is evidence of a negative tuberculin skin test (mantoux)

3 months before travel

People who have had TB in the past and those with a positive mantoux skin test. This is a live vaccine therefore conditions such as HIV or cancer is contra-indicated. Many people with conditions however can successfully receive BCG with specific nurse management. Those who have received a live vaccination within the last 4 weeks eg MMR or Yellow Fever should delay BCG vaccination by one month. However live vaccines can be given together on the same day.

Although no adverse reports, it is best to avoid BCG in pregnancy. BCG is not contra-indicated in breast feeding therefore can be given after delivery.

25 years – life

A mild local reaction at the BCG injection site is typical. A small blister like response and local reaction is to be expected and this is evidence that the vaccination has been successful, leaving a characteristic small scar.

£70 per dose